Analytical testing supports nearly every decision in drug development, from early characterization through stability studies, release testing, and commercial quality control. As programs advance, sponsors face growing demands for method development, validation, and data that can withstand regulatory review, often while working against tight timelines.
Planning analytical work early can help teams avoid delays, maintain consistency during technology transfer, and build a stronger foundation for scale-up and commercial supply. In this edition of the Outsourced Pharma Capabilities Update (OPCU), explore how service providers are approaching analytical development and testing across the product life cycle, with perspectives on method validation, stability programs, and managing outsourced testing partnerships. Watch the presentations below for practical considerations that can help strengthen your analytical strategy.
Recent Sessions Available On-Demand
AI Drug Manufacturing & Viral Vectors – October 2026
mRNA & Packaging, Labeling & Logistics – October 2026
Fill/Finish – October 2026
ADC – October 2026
Upcoming OPCU Topics & Times
Enabling ADC Success | 12/1/2026, PM Session
Mastering Aseptic Fill-Finish | 12/1/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.